NasdaqGS:COOMedical Equipment
Does CooperCompanies’ US$2 Billion Free Cash Flow Outlook Shift the Bull Case for COO?
In the lead-up to its recent earnings release, CooperCompanies drew attention as Wall Street projected quarterly earnings of US$1.10 per share on revenue of US$1.05 billion, with particular focus on the performance of its CooperVision and CooperSurgical segments.
At the same time, management’s guidance for roughly US$2.00 billion in free cash flow over the next three years has sharpened interest in how the company may balance debt reduction and share repurchases.
Now, we’ll examine how these...